BridgeMD
Pericapsular nerve group (PENG) block for postoperative pain after peri-acetabular osteotomy
EU CTIS ID: 2024-513688-25-01
What this study is testing
To investigate if pericapsular nerve group (PENG) block is superior to placebo in decreasing immediate pain and other complications after periacetabular osteotomy (PAO)
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients ≥ 18 years old
- Informed consent
- Scheduled for periacetabular osteotomy under general anesthesia with intubation
- American Society of Anesthesiologists (ASA) physical status classification I to III
- Can read and understand Danish
You likely can't join if
- Known allergy to ropivacaine
- Daily use of opioids, gabapentin or tricyclic antidepressant (regardless of dose) within the last four weeks prior to surgery
- Contraindications to Celocoxib, NSAIDs or paracetamol
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.